D054703Chemicals & DrugsD08.811.277.352.640.150.400D12.644.360.008.400D12.776.476.008.400590.99736Cyclic Nucleotide Phosphodiesterases, Type 4prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson29061142Liu S, Liu Y, Zhang Q, Wu J, Liang J, Yu S, Wei GH, White KP, Wang XGenome biologySystematic identification of regulatory variants associated with cancer risk. Genome Biol. 2017 10 23; 18(1):194.Genome Biol2017-10-23T00:00:002017Systematic identification of regulatory variants associated with cancer risk.Medicine-Pulmonary and Critical Care20701803Johnson KR, Nicodemus-Johnson J, Danziger RSBMC evolutionary biologyAn evolutionary analysis of cAMP-specific Phosphodiesterase 4 alternative splicing. BMC Evol Biol. 2010 Aug 11; 10:247.BMC Evol Biol2010-08-11T00:00:002010An evolutionary analysis of cAMP-specific Phosphodiesterase 4 alternative splicing.22293537Kiyotani K, Uno S, Mushiroda T, Takahashi A, Kubo M, Mitsuhata N, Ina S, Kihara C, Kimura Y, Yamaue H, Hirata K, Nakamura Y, Zembutsu HPharmacogenetics and genomicsA genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapy. Pharmacogenet Genomics. 2012 Apr; 22(4):229-35.Pharmacogenet Genomics2012-04-01T00:00:002012A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapy.0.1962640.01760965research area of0.4616510.059717313subject area forMedicineUniversity of ChicagoJamesO'DonnellJames O'Donnell41.78927490000000-87.601250000000001833O'Donnell, JamesPostdoctoral FellowAlanLeffAlan Leff41.78927490000000-87.601250000000002537Leff, AlanEmeritus/EmeritaMary ElizabethStrekMary Elizabeth Strek41.78927490000000-87.601250000000002563Strek, Mary ElizabethProfessorYusukeNakamuraYusuke Nakamura41.78927490000000-87.60125000000000582Nakamura, YusukeEmeritus/Emerita, ProfessorStephenHanauerStephen B. Hanauer41.78927490000000-87.60125000000000660Hanauer, StephenEmeritus/Emeritatrue1Emeritus/Emerita, ProfessorEmeritus/Emerita, Professortrue1Emeritus/EmeritaEmeritus/Emeritatrue1Postdoctoral FellowPostdoctoral Fellowtrue1Emeritus/EmeritaEmeritus/Emeritatrue1ProfessorProfessor23003922Wang ZZ, Zhang Y, Liu YQ, Zhao N, Zhang YZ, Yuan L, An L, Li J, Wang XY, Qin JJ, Wilson SP, O'Donnell JM, Zhang HT, Li YFBritish journal of pharmacologyRNA interference-mediated phosphodiesterase 4D splice variants knock-down in the prefrontal cortex produces antidepressant-like and cognition-enhancing effects. Br J Pharmacol. 2013 Feb; 168(4):1001-14.Br J Pharmacol2013-02-01T00:00:002013RNA interference-mediated phosphodiesterase 4D splice variants knock-down in the prefrontal cortex produces antidepressant-like and cognition-enhancing effects.26308168Huang H, Ma ZC, Wang YG, Hong Q, Tan HL, Xiao CR, Liang QD, Tang XL, Gao YInternational journal of clinical pharmacology and therapeuticsFerulic acid alleviates Aß25-35- and lipopolysaccharide-induced PC12 cellular damage: a potential role in Alzheimer's disease by PDE inhibition. Int J Clin Pharmacol Ther. 2015 Oct; 53(10):828-37.Int J Clin Pharmacol Ther2015-10-01T00:00:002015Ferulic acid alleviates Aß25-35- and lipopolysaccharide-induced PC12 cellular damage: a potential role in Alzheimer's disease by PDE inhibition.